Patient and tumor related features in 427 screen-detected breast cancers

E. Manfrin , D. Reghellin , N. Schiavo , A. Remo
Histopathology 53 49 -50

2008
Caratteristiche clinico-patologiche dei carcinomi mammari insorti in lesioni scleroelastotiche. Management di 37 casi.

E. Manfrin , F. Pedica , D. Reghellin , N. Schiavo
Pathologica 100 ( 4) 379 -379

2008
2008
Cost-effectiveness of a stepwise approach to the use of FNAC and CNB in the assessment of breast abnormalities

D. Dalfior , Erminia Manfrin , F. Pedica , D. Reghellin
XXVIIth international congress of the international academy of pathology 53 50 -51

2008
Carcinomi della mammella con valutazione dello stato di Her-2 mediante immunoistochimica ed ibridazione in situ fluorescente: impatto clinico nella selezione dei pazienti per la terapia con Herceptin

D. Dalfior , E. Manfrin , D. Reghellin , F. Menestrina
Società Italiana di Anatomia Patologica e Citopatologia Diagnostica (SIAPEC-IAP) 98

2006
Wnt (canonical and non canonical) pathways in breast carcinoma with extensive vascular invasion and inflammatory breast carcinoma

E. Manfrin , P. Parcesepe , A. Remo , I. Simeone
Pathology Research and Practice 219 153347 -153347

2021
Uterine PEComa with aggressive behavior: A review with an additional case of spontaneous vaginal expulsion.

M. Gentile , M. Zinna , C. Zanella , A. Costanza
Pathology Research and Practice 216 ( 6) 152991

1
2020
Subglotic malt-lymphoma of the larynx: an unusual presentation of chronic cough.

M. Zapparoli , A.R. Trolese , A. Remo , S. Sina
International Journal of Immunopathology and Pharmacology 27 ( 3) 461 -465

5
2014
532 POSTER Relationships between HER2 and the leptin (Ob/ObR) system in breast cancer

E. Fiorio , A. Auriemma , A. Mercanti , A. Remo
Ejc Supplements 5 ( 4) 99

2007
Occult inflammatory breast cancer: review of clinical, mammographic, US and pathologic signs.

Cristian Pattaro , Erminia Manfrin , Maria-Beatrice Gaioni , Andrea Remo
Radiologia Medica 109 ( 4) 308 -320

12
2005
KRAS mutations and M2PK upregulation in stool samples from individuals with positive fecal occult blood tests screened for colorectal cancer.

Roberto Vendraminelli , Andrea Remo , Paolo Battaglia , Antonio Conti
Tumori 100 ( 2) 122 -127

2
2014
Role of molecular markers in diagnosis and prognosis of renal cell carcinoma.

Paolo Cossu-Rocca , Fabio Menestrina , Vincenzo Ficarra , Andrea Remo
Analytical and Quantitative Cytology and Histology 29 ( 1) 41 -49

40
2007
Imaging of the male breast.

Elisabetta Jellici , Roberto Pozzi Mucelli , Andrea Remo , Franco Bonetti
Radiologia Medica 110 574 -588

8
2005
CARCINOMI DELLA MAMMELLA POSITIVI ALL'IMMUNOESPRESSIONE PER HER-2: VALUTAZIONE CON METODICA FISH DEI CASI CON IMMUNOESPRESSIONE INTRATUMORALE ETEROGENEA

Erminia Manfrin , P Capelli , Daniela Reghellin , F Menestrina
Congresso Nazionale Italiano Anatomia Patologica (SIAPEC-IAP) 569

2006
Breast cancer with both assessment of Her2/Neu overexpression and gene amplification:clinical impact in selecting patients for drug treatment

Erminia Manfrin , Daniela Reghellin , Fabio Menestrina , Andrea Remo
XXVI INTERNATIONAL CONGRESS OF INTERNATIONAL ACADEMY OF PATHOLOGY 16

2006
Diagnostic management of occult nodal lymphangioleiomyomatosis detected during pelvic cancer staging. Localized finding or systemic disease

Erminia Manfrin , Pietro Parcesepe , Andrea Remo , Massimo Pancione
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 36 ( 1) 33 -38

1
2019
Current prognostic and predictive biomarkers for gastrointestinal tumors in clinical practice.

Matteo Fassan , Aldo Scarpa , Andrea Remo , Giovanna De Maglio
Pathologica 112 ( 3) 248 -259

2
2020
Un’insolita localizzazione di mieloma tracheale: l’importanza dell’analisi morfologica della curva spirometrica flusso-volume

Andrea Remo , Claudio Micheletto , Pierfranco Foccoli
Rassegna di Patologia dell'Apparato Respiratorio 31 329 -332

2016